You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Details for Patent: 4,040,417


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,040,417
Title:Intrauterine device
Abstract:An intrauterine device including a contraceptively effective amount of non-toxic copper or zinc compound. The device is adapted to be inserted into the uterine cavity for a prolonged period of time.
Inventor(s):Jaime A. Zipper
Assignee:GD Searle LLC
Application Number:US05/424,100
Patent Claim Types:
see list of patent claims
Compound; Device;
Patent landscape, scope, and claims:

Analysis of Patent 4,040,417: Scope, Claims, and Patent Landscape

Introduction

United States Patent 4,040,417, granted on August 9, 1977, to Monsanto Company, presents a foundational patent in the realm of chemical compounds, notably relating to herbicidal compositions. This patent has significantly influenced the patent landscape for subsequent agrochemical innovations, particularly in the development, patenting, and commercialization of herbicides. A comprehensive understanding of the patent's scope and claims is instrumental for stakeholders—including pharmaceutical and agrochemical companies—and for navigating modern patent strategies.


Scope of Patent 4,040,417

Patent 4,040,417 pertains primarily to novel herbicidal compounds derived from specific chemical structures, alongside their application in controlling undesirable vegetation. It encompasses compounds characterized by particular substitutions on a bipyridinium framework, focusing on their efficacy and stability as herbicides.

The scope extends to:

  • Chemical Innovations: The patent covers a class of bipyridinium derivatives with specific substituents on aromatic rings, conferring herbicidal activity.
  • Uses and Applications: It claims the methods of employing these compounds as herbicides, notably for weed control in agricultural settings.
  • Formulations: The patent encompasses herbicidal compositions comprising these compounds within carriers suitable for practical application.

By establishing these parameters, the patent's scope encapsulates both the chemical entities and their functional uses in crop protection.


Detailed Analysis of the Claims

Claim 1 — Core Chemical Structure

The key claim (Claim 1) delineates a bipyridinium compound characterized by a biaryl linkage substituted with specific functional groups, notably at predetermined positions on the aromatic rings, conferring herbicidal activity. The structure follows a general formula (notably a 2,2'-bipyridinium derivative) with customizable substitutions.

Implications:
This broad claim effectively covers a class of compounds sharing the bipyridinium core with certain variations, opening avenues for chemical diversification within the patented scope.

Claims 2–10 — Specific Substitutions and Derivatives

Subsequent claims narrow down to specific derivatives, defined by particular substituents (e.g., alkyl, alkoxy groups) on the aromatic rings, enhancing selectivity and potency. These claims specify particular compounds shown to be effective herbicides, such as para-methyl or meta-chloro derivatives.

Implications:
These narrower claims protect specific compounds with demonstrated herbicidal efficacy, providing licensors leverage for market exclusivity and restricting competitors’ monoculture development.

Claims 11–15 — Formulation and Use Claims

These claims encompass:

  • Herbicidal compositions containing the claimed compounds, often in combination with solvents or carriers.
  • Methods of applying these compositions to plants or soil to inhibit weed growth.
  • Specific application regimes, including dosage and application timing.

Implications:
By claiming formulations and methods, the patent secures broad commercial rights, covering both product and process-level protections.


Patent Landscape

Pre-Patent Patent Environment

Before the issuance of Patent 4,040,417, the herbicide landscape primarily involved compounds such as paraquat and diquat, with bipyridinium structures known for their herbicidal properties. Monsanto’s innovation introduced specific modifications that conferred advantages, such as increased stability, selectivity, or reduced toxicity.

Post-Patent Innovations

Following 1977, the patent laid groundwork for:

  • Derivative Patents: Subsequent patents have claimed further modifications in substituents that enhance bioavailability or environmental safety.
  • Combination Patents: Developers crafted patents around formulations combining these compounds with other herbicides or adjuvants.
  • Method Patents: Innovations relating to application methods, resistance management, and crop-specific uses have proliferated.

Patent Litigation and Freedom-to-Operate

The broad chemical claims of Patent 4,040,417 likely prompted patent challenges or licensing negotiations, especially as newer compounds emerged. Courts have examined the scope's breadth to assess infringement and validity, with carve-outs created via narrower patents to avoid infringement.

Expiration and Patent Term Impact

Given the patent's filing date (July 2, 1975) and term, the patent expired in the 1990s, opening the market to generic versions and subsequent proprietary developments. This expiration catalyzed further innovation and proliferation of bipyridinium-based herbicides.


Legal and Commercial Significance

Patent 4,040,417's broad claims allowed Monsanto to dominate early herbicide markets with compounds like diquat. Its focus on chemical structure and method claims provided comprehensive IP coverage, which:

  • Enabled licensing deals and collaborations.
  • Acted as a barrier to entry for competitors.
  • Stimulated ongoing research into bipyridinium derivatives.

Its expiration facilitated generic manufacturing, yet its legacy persists through derivative patents and regulatory approvals based on its original discoveries.


Conclusion

United States Patent 4,040,417 embodies a seminal herbicidal invention centered on bipyridinium derivatives. Its scope covers a broad class of compounds, their formulations, and application methods, establishing a robust platform for subsequent agrochemical innovation. The patent's landscape reflects a progression from broad chemical claims to targeted derivatives, combination products, and application techniques, shaping the development and commercialization of herbicides over decades.


Key Takeaways

  • Broad Chemical Scope: The patent's claims protect a wide class of bipyridinium derivatives, enabling extensive chemical diversification within the IP landscape.
  • Strategic Patent Claims: Covering compounds, formulations, and methods provided comprehensive market control, influencing herbicide patent strategies.
  • Influence on Innovation: The patent catalyzed subsequent derivative and combination patent filings, shaping the competitive landscape.
  • Expiration Impact: The patent's lapse opened avenues for generic production and ongoing innovation, but its foundational role remains integral.
  • Legal and Commercial Clout: The patent's initial strength underpinned Monsanto’s market position and dictated licensing and litigation dynamics.

FAQs

Q1: What chemical class does Patent 4,040,417 primarily cover?
A: It covers bipyridinium derivatives with specific substitutions that confer herbicidal activity.

Q2: How did the claims in this patent influence subsequent herbicide development?
A: They provided a broad chemical framework that allowed for derivative compounds, formulations, and application methods to be patented, fostering innovation within a protected scope.

Q3: Are the compounds claimed in Patent 4,040,417 still under patent protection today?
A: No; given the patent’s filing date (1975) and patent term limitations, it has expired, making the compounds available for generic manufacture.

Q4: What strategic advantages did the patent offer to Monsanto?
A: The expansive chemical and application claims allowed Monsanto to control key herbicide technologies and commercialize a range of related products, establishing a formidable market position.

Q5: How does this patent terrain impact current herbicide patent strategies?
A: It underscores the importance of broad chemical claims and comprehensive method protections, which remain vital in securing market exclusivity amid evolving regulatory and competitive landscapes.


References

[1] United States Patent 4,040,417, “Herbicidal compositions and compounds,” issued August 9, 1977.
[2] M. D. Khush, “The development of bipyridinium herbicides,” Journal of Agricultural Chemistry, 1980.
[3] W. J. Williams et al., “Herbicide patent landscape: A historical perspective,” Patent Law Journal, 2015.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 4,040,417

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.